Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women
Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women
The overall purpose of this application is to evaluate the efficacy of an intervention
 designed to decrease health disparities in pregnant, emotionally distressed, minority women.
 This randomized controlled trial will test a six session (spaced over 18 weeks) cognitive
 behavioral skills building (CBSB) prenatal care intervention (specifically designed and based
 on prior research for pregnant minority women experiencing emotional distress) at three sites
 (Jacobi Medical Center, New York City and The Ohio State University Total Health and Wellness
 Clinic, and The Ohio State University Wexner Medical Center OB/GYN Columbus, Ohio.
A randomized controlled trial will test a cognitive behavioral skills building intervention
 (COPE-P) in Black and Hispanic women experiencing emotional distress in two sites (New York
 and Ohio) to determine if the intervention leads to better health behaviors, better
 psychosocial health (anxiety, stress, and depressive symptoms), and improved birth and
 post-natal outcomes in women experiencing emotional distress. Developing scalable prenatal
 interventions designed to improve birth outcomes as well as maternal physical and
 psychosocial health is essential to decrease health disparities in pregnant minority women.
Inclusion Criteria:

 -  Pregnant women between the ages of 18-40 years old

 -  Pregnant women experiencing an uncomplicated singleton pregnancy of less than 19 weeks

 -  Self-identified as either Black or Hispanic

 -  Able to read and speak English.

 -  The child participants born to the participants will have their record accessed for
 data collection.

 Exclusion Criteria:

 -  Women with chronic medical conditions (e.g., hypertension, or diabetes), are currently
 receiving treatment or therapy for a psychiatric diagnosis, or have participated in
 this study with a prior pregnancy.

 -  Women with obstetrical complications, such as preeclampsia, gestational diabetes, or
 fetal abnormalities.